| Size & multiples | |||
| Market Cap | $303.07B | Enterprise Value | $292.32B |
| P/E (TTM) | 22.21× | PEG (trailing) | 0.71× |
| P/S | 5.56× | P/FCF | 17.22× |
| EV/EBITDA | 15.72× | EV/EBIT | 16.57× |
| EV/Sales | 5.36× | EV/FCF | 16.61× |
| FCF Yield | 5.81% | Buyback Yield | 3.01% |
| Owner Earnings (TTM) | $13.98B | Owner Earnings Yield | 4.61% |
| Shareholder Yield | 5.59% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.45 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.27% |
| After-tax Cost of Debt | 143.28% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 167.74% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 6.58% | ROIC | 43.62% |
| EVA Spread (ROIC−WACC) | 37.04% | EVA | $13.26B |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows latest annual · EPS TTM $7.15 · revenue TTM $54.53B · FCF TTM $17.60B
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| Net Margin | 25.6% | -21.2% | -325.3%–7.2% | 92 ↑strong |
| Operating Margin | 32.4% | -34.5% | -552.0%–8.0% | 96 ↑strong |
| ROE | 31.0% | -36.8% | -92.5%–4.5% | 95 ↑strong |
